A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE3

Conditions

Relapsing-remitting Multiple Sclerosis (RRMS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

LLC "Medis", Nizhny Novgorod, Russia
Sokolova

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (RRMS) · Anti-CD20 Therapy

Abroad (travel likely)RecruitingPHASE3

Montpellier, France

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Multiple Sclerosis · RRMS · Relapsing Remitting MS

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Multiple Sclerosis (MS) · Relapsing-remitting Multiple Sclerosis (RRMS) · Secondary-progressive Multiple Sclerosis (SPMS)

Abroad (travel likely)Recruiting

Basel, Switzerland

RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies

Multiple Sclerosis

Abroad (travel likely)Recruiting

Milan, Italy